PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Hospitals – Market size and forecast 2017-2022 • Home healthcare – Market size and forecast 2017-2022 • Others – Market size and forecast 2017-2022 • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Launch of innovative products • Increased online presence of vendors • Increased M&A PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abaxis • Abbott • ACON Laboratories • Akers Biosciences • F. Hoffmann-La Roche PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global medical devices market segmentation Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global cholesterol testing devices market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global cholesterol testing devices – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Customer landscape Exhibit 19: End-user – Market share 2017-2022 (%) Exhibit 20: Comparison by end-user Exhibit 21: Hospitals – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Hospitals – Year-over-year growth 2018-2022 (%) Exhibit 23: Home healthcare – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Home healthcare – Year-over-year growth 2018-2022 (%) Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn) Exhibit 26: Others – Year-over-year growth 2018-2022 (%) Exhibit 27: Market opportunity by end-user Exhibit 28: Global – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Abaxis – Overview Exhibit 46: Abaxis – Business segments Exhibit 47: Abaxis – Organizational developments Exhibit 48: Abaxis – Geographic focus Exhibit 49: Abaxis – Segment focus Exhibit 50: Abaxis – Key offerings Exhibit 51: Abbott – Overview Exhibit 52: Abbott – Business segments Exhibit 53: Abbott – Organizational developments Exhibit 54: Abbott – Geographic focus Exhibit 55: Abbott – Segment focus Exhibit 56: Abbott – Key offerings Exhibit 57: ACON Laboratories – Overview Exhibit 58: ACON Laboratories – Business segments Exhibit 59: ACON Laboratories – Organizational developments Exhibit 60: ACON Laboratories – Key offerings Exhibit 61: Akers Biosciences – Overview Exhibit 62: Akers Biosciences – Product segments Exhibit 63: Akers Biosciences – Organizational developments Exhibit 64: Akers Biosciences – Geographic focus Exhibit 65: Akers Biosciences – Key offerings Exhibit 66: F. Hoffmann-La Roche – Overview Exhibit 67: F. Hoffmann-La Roche – Business segments Exhibit 68: F. Hoffmann-La Roche – Organizational developments Exhibit 69: F. Hoffmann-La Roche – Geographic focus Exhibit 70: F. Hoffmann-La Roche – Segment focus Exhibit 71: F. Hoffmann-La Roche – Key offerings

Abaxis Abbott ACON Laboratories Akers Biosciences F. Hoffmann-La Roche